These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33220857)

  • 1. Comparing the Efficacy of Cancer Therapies between Subgroups in Basket Trials.
    Palmer AC; Plana D; Sorger PK
    Cell Syst; 2020 Nov; 11(5):449-460.e2. PubMed ID: 33220857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal two-stage designs for exploratory basket trials.
    Zhou H; Liu F; Wu C; Rubin EH; Giranda VL; Chen C
    Contemp Clin Trials; 2019 Oct; 85():105807. PubMed ID: 31260789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian and frequentist approaches to sequential monitoring for futility in oncology basket trials: A comparison of Simon's two-stage design and Bayesian predictive probability monitoring with information sharing across baskets.
    Kaizer A; Zabor E; Nie L; Hobbs B
    PLoS One; 2022; 17(8):e0272367. PubMed ID: 35917296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rBMA: A robust Bayesian Model Averaging Method for phase II basket trials based on informative mixture priors.
    Wang X; Wei W
    Contemp Clin Trials; 2024 May; 140():107505. PubMed ID: 38521384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian basket trial design with exchangeability monitoring.
    Hobbs BP; Landin R
    Stat Med; 2018 Nov; 37(25):3557-3572. PubMed ID: 29984488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revolutionizing cancer drug development: Harnessing the potential of basket trials.
    Subbiah V; Burris HA; Kurzrock R
    Cancer; 2024 Jan; 130(2):186-200. PubMed ID: 37934000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basket Trials: Review of Current Practice and Innovations for Future Trials.
    Hobbs BP; Pestana RC; Zabor EC; Kaizer AM; Hong DS
    J Clin Oncol; 2022 Oct; 40(30):3520-3528. PubMed ID: 35537102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbrella and basket trials in oncology: ethical challenges.
    Strzebonska K; Waligora M
    BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient basket trial design.
    Cunanan KM; Iasonos A; Shen R; Begg CB; Gönen M
    Stat Med; 2017 May; 36(10):1568-1579. PubMed ID: 28098411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of published, basket trials in cancer medicine.
    Hazim A; Prasad V
    Eur J Cancer; 2018 Sep; 101():244-250. PubMed ID: 30096705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.
    Renfro LA; Sargent DJ
    Ann Oncol; 2017 Jan; 28(1):34-43. PubMed ID: 28177494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment.
    Lengliné E; Peron J; Vanier A; Gueyffier F; Kouzan S; Dufour P; Guillot B; Blondon H; Clanet M; Cochat P; Degos F; Chevret S; Grande M; Putzolu J;
    Lancet Oncol; 2021 Oct; 22(10):e430-e434. PubMed ID: 34592192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific activity of precision medicines in the NCI-MATCH trial.
    Zhou I; Plana D; Palmer AC
    medRxiv; 2023 Mar; ():. PubMed ID: 37034644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new basket trial design based on clustering of homogeneous subpopulations.
    Krajewska M; Rauch G
    J Biopharm Stat; 2021 Jul; 31(4):425-447. PubMed ID: 34236938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016.
    Ladanie A; Schmitt AM; Speich B; Naudet F; Agarwal A; Pereira TV; Sclafani F; Herbrand AK; Briel M; Martin-Liberal J; Schmid T; Ewald H; Ioannidis JPA; Bucher HC; Kasenda B; Hemkens LG
    JAMA Netw Open; 2020 Nov; 3(11):e2024406. PubMed ID: 33170262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints.
    Chi X; Yuan Y; Yu Z; Lin R
    Biom J; 2024 Mar; 66(2):e2300122. PubMed ID: 38368277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
    Carden CP; Sarker D; Postel-Vinay S; Yap TA; Attard G; Banerji U; Garrett MD; Thomas GV; Workman P; Kaye SB; de Bono JS
    Drug Discov Today; 2010 Feb; 15(3-4):88-97. PubMed ID: 19961955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.